All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Corporate Bonds

Merck gets $6.5bn after poor results as US blockbusters fly

Merck shrugged off concerns about its performance to lead more than $33bn of US high grade issuance this week, as the drugmaker became the latest big US company to finance a share buyback through the bond market.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree